Hylan G-F 20 Versus Low Molecular Weight Hyaluronic Acids for Knee Osteoarthritis: A Meta-Analysis Hongmou ZhaoHongliang LiuCheng Liu Systematic Review 19 July 2016 Pages: 387 - 396
Advances in the Treatment of Non–small Cell Lung Cancer: Focus on Nivolumab, Pembrolizumab, and Atezolizumab Konstantinos LeventakosAaron S. Mansfield Review Article 13 July 2016 Pages: 397 - 405
Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis Shingo NakayamadaSatoshi KuboYoshiya Tanaka Review Article 31 August 2016 Pages: 407 - 419
Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Vasileios S. SkourasCharis MaragkosKonstantinos N. Syrigos Review Article 26 September 2016 Pages: 421 - 439
Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment Simon GerberAnnette GaidaMartin Imboden Original Research Article Open access 19 September 2016 Pages: 441 - 451
BAY 81-8973 (Octocog Alfa; Kovaltry®): A Review in Haemophilia A Gillian M. Keating Adis Drug Evaluation 31 August 2016 Pages: 453 - 459
Talimogene Laherparepvec: A Review in Unresectable Metastatic Melanoma Karly P. Garnock-Jones Adis Drug Evaluation 11 August 2016 Pages: 461 - 468
Infliximab Biosimilar (CT-P13; Infliximab-dyyb): A Review in Autoimmune Inflammatory Diseases Hannah A. BlairEmma D. Deeks Adis Drug Evaluation 20 September 2016 Pages: 469 - 480
Erratum to: Etanercept (SB4): A Review in Autoimmune Inflammatory Diseases Celeste B. BurnessSean T. Duggan Erratum 29 September 2016 Pages: 481 - 481
Erratum to: Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis Shingo NakayamadaSatoshi KuboYoshiya Tanaka Erratum 03 October 2016 Pages: 483 - 483
